Publication | Closed Access

Prolonged tamoxifen treatment increases relapse-free survival for patients with primary breast cancer expressing high levels of VEGF

Prolonged Tamoxifen TreatmentBreast OncologyMedicineCancer RecurrenceRelapse-free SurvivalPathologyCancer GrowthHigh LevelsBreast CancerCancer TreatmentOncologyRadiation OncologyEndocrine-related Cancer